Apalutamide (ARN-509) is a potent, competitive androgen receptor (AR) antagonist (IC50 = 16 nM). It prevents AR nuclear localization and DNA binding. Orally bioavailable, it suppresses tumor growth in castration-resistant prostate cancer models and is valuable for studying androgen signaling. Reagent grade, for research use only.
Usually ships within 24 hours.